Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001879547-22-000001
Filing Date
2022-11-01
Accepted
2022-11-01 13:42:34
Documents
1
Effectiveness Date
2022-11-01
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12497
  Complete submission text file 0001879547-22-000001.txt   13679
Mailing Address 333 S. GRAND AVENUE 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 S. GRAND AVENUE 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Life Sciences Lending Fund, L.P. (Filer) CIK: 0001879547 (see all company filings)

EIN.: 981604604 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-412278 | Film No.: 221349489